Subtitle
Proton and Heavy Particle Intracranial Radiosurgery.
Subtitle
Proton and Heavy Particle Intracranial Radiosurgery.
Proto therapy Time
January 2021
Executive summary
This review provides a comprehensive overview of clinical evidence in the use of particle therapy-based radiosurgery. The vast majority of available data are single institution retrospective studies that utilized protons. While there are theoretical benefits to using particles over photons for intracranial radiosurgical applications, prospective data are needed to validate the safety and efficacy of this treatment modality.
Top cancer treatments
Related contents
Proton Therapy Publication
March 2024
How proton therapy fits into the management of adult intracranial tumors.
Proton Therapy Publication
March 2024
Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Proton Therapy Publication
March 2024
Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma.
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group.
Proton Therapy Publication
January and February 2023
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma.
Proton Therapy Publication
January and February 2023
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
Proton Therapy Publication
December 2023
Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.
Proton Therapy Publication
September and October 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
Proton Therapy Publication
September and October 2023
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients.